Curacel
Security and trust center evidence
AI-Powered Infrastructure for Insurance & Healthcare
Summary
CertReports found no public compliance evidence for Curacel yet. That does not mean the vendor lacks attestations; it means no registry row, auditor confirmation or vendor statement has been captured. Vendors can add evidence in minutes.
Reviewer brief
CertReports found no public compliance evidence for Curacel as of unknown date. This does not mean the vendor is non-compliant. It means CertReports found no public evidence at the last check.
Facts only, each dated; nothing here is inferred, scored or advised.
Among healthcare vendors
0verified rows
Category median 0, across 91 indexed healthcare vendors. Curacel has no registry-verified row yet, like 52 percent of them; its evidence is vendor-stated or reported.
Compare with similar vendors
Pick your own comparisonCompliance grid
Legal artefacts
No DPA, BAA or subprocessor list has been captured from a public page yet. Registry rows above do not depend on this.
Subprocessors
No subprocessor list captured yet.
Similar vendors with evidence
Related by product tags and the Healthcare category, ranked by shared tags, description similarity and overlapping evidence. Never by popularity.
VIIHEALTH
Healthcare
YOUR ANSWER TO BETTER ENGAGEMENT Transforming Healthcare Engagement with
Salucro Healthcare Solutions
Healthcare
Salucro is a healthcare financial technology company exclusively focused on patient payments and
Athenahealth
Healthcare
Athenahealth, Inc. is a privately held American company that provides cloud-based SaaS healthcare technology and network-enabled services
RevSpring
Healthcare
RevSpring connects access, engagement, and payments to reduce friction and modernize the healthcare experience for providers and
Evidence against regulations
All regulations for CuracelHow much of each regulation’s vendor requirements Curacel’s public evidence reaches.
Reviewing a vendor on public evidence
All articlesWhat Is a Trust Centre? Vendor Evidence vs Office Settings
Solomon Amos · 28 Oct 2026 · 10 min read